Results 51 to 60 of about 33,815 (233)

Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the Caerphilly Study [PDF]

, 2001
We have previously reported that plasma fibrin D-dimer (a marker of turnover of cross-linked Fibrin) showed a strong and independent association with incident ischaemic heart disease (IHD) in the Caerphilly Study cohort of 1,998 men a-ed 49-65.
Lowe, G.D.O., Rumley, A., Rumley, J., Sweetnam, P.M., Yarnell, J.W.G.   +4 more
core   +1 more source

Patients Experiencing Unsuccessful Defibrillation From Implantable Cardiac Devices Remain at Elevated Risk Despite Procedural Management

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Unsuccessful defibrillation therapy in patients with implantable cardiac defibrillators (ICDs) and ventricular tachytherapies may occur due to patient and/or device‐related factors; appropriate management strategies after failed defibrillation therapy have been incompletely described.
Nathaniel Christian‐Miller, Muazzum Shah, Kelly Arps, Amrish Deshmukh, Jackson Liang, Ryan Cunnane, Krit Jongnarangsin, Frank Pelosi, Hakan Oral, Michael Ghannam   +9 more
wiley   +1 more source

Pharmacological Cardioversion With Antazoline in Atrial Fibrillation: The Results of the CANT Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Antazoline mesylate represents an antihistamine capable of rapid and safe cardioversion of atrial fibrillation, yet evidence concerning its efficacy in comparison to other medications is insufficient.
Maciej T. Wybraniec, Wojciech Wróbel, Katarzyna Wilkosz, Karolina Wrona, Karolina Bula, Katarzyna Mizia‐Stec   +5 more
doaj   +1 more source

Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram [PDF]

, 2004
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Neither the natural history of AF nor its response to therapy are sufficiently predictable by clinical and echocardiographic parameters.
Bollmann, Andreas, Husser, Daniela, Olsson, Bertil, Sornmo, Leif, Stridh, Martin   +4 more
core  

The Risk of Thromboembolic Complications in Fontan Patients with Atrial Flutter/fibrillation Treated with Electrical Cardioversion [PDF]

, 2016
Atrial flutter or fibrillation (AFF) remains a major chronic complication of the Fontan procedure. This complication further predisposes this patient population to thromboembolic events.
Cordes, Timothy M., Kean, Adam C., Lin, Jiuann-Huey I.   +2 more
core   +1 more source

Left Atrial Posterior Wall Functional Remodeling in Paroxysmal and Persistent Atrial Fibrillation. A Pilot Study

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background The left atrial posterior wall (LAPW) is often targeted in atrial fibrillation (AF) ablation due to its shared properties with pulmonary veins. However, substrate‐guided approaches using structural markers have shown inconsistent results.
Michael M. Malaty, Natasha Trevaskis, Kerissa Govender, Aaron L. Sverdlov, Bradley R. Wilsmore, Malcolm Barlow, Nicholas Jackson, Gwilym M. Morris   +7 more
wiley   +1 more source

Pharmacological cardioversion for atrial fibrillation and flutter* [PDF]

, 2006
Atrial fibrillation is the commonest cardiac dysrhythmia. It is associated with significant morbidity and mortality. There are two approaches to the management of atrial fibrillation: controlling the ventricular rate or converting to sinus rhythm in ...
Cordina, J, Mead, G
core  

Hemodynamic Consequences and Clinical Outcomes With Intravenous Lidocaine Infusion in Patients With Atrial Fibrillation

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Intravenous lidocaine is frequently used for refractory ventricular arrhythmia (VA). Atrial fibrillation (AF) is a common comorbidity in VA patients. Lidocaine poses theoretical risks of hemodynamic compromise and pro‐arrhythmia, including AF with rapid ventricular rates (RVR).
Andrea N. Keithler, Zameer Abedin, Deborah Furman, Luke Schwarz, Marc C. Engels, Roger A. Freedman, Klitos Konstantinidis, H. Immo Lehmann, Ravi Ranjan, Benjamin A. Steinberg, T. Jared Bunch   +10 more
wiley   +1 more source

Cardioversion Efficacy Using Pulsed Biphasic or Biphasic Truncated Exponential Waveforms: A Randomized Clinical Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
Background Several different defibrillators are currently used for cardioversion and defibrillation of cardiac arrhythmias. The efficacy of a novel pulsed biphasic (PB) waveform has not been compared to other biphasic waveforms.
Anders S. Schmidt, Kasper G. Lauridsen, Kasper Adelborg, Peter Torp, Leif F. Bach, Simon M. Jepsen, Nete Hornung, Charles D. Deakin, Hans Rickers, Bo Løfgren   +9 more
doaj   +1 more source

Non-valvular atrial fibrillation and stroke : implications for management [PDF]

, 1995
Nonvalvular Atrial Fibrillation is more prevalent with increasing age. It is associated with a six-fold excess risk of stroke; and a cumulative lifetime stroke risk of 35%. 15% of ischaemic strokes are directly attributable to it.
Tilney, Myra Kay
core